News Tagged ‘blood thinners

Surgeons hopeful about new alternatives to heparin

Surgeons are anticipating the approval of new blood thinners that could replace more conventional methods currently in use, according to the Ortho SuperSite, a resource for orthopedic surgeons and rheumatologists.

Read the rest of this entry »

Heart device may eliminate need for heparin, warfarin

A small device implanted in the heart to stop blood clots from triggering strokes could serve as an alternative to blood thinners such as heparin and warfarin, according to a new study conducted by the device’s maker, Atritech, Inc. The device, called the Watchman, is designed specifically for patients with atrial fibrillation, a type of irregular heartbeat.

Read the rest of this entry »

Head injury protocol reduces death rate for patients on blood thinners

Blood thinners, like heparin, are routinely administered or prescribed to patients to help prevent blot clots that can lead to heart attacks or strokes. But if a patient taking blood thinners bumps his head, he is at greater risk for undetected brain bleeds and death, according to Emax Health.

Read the rest of this entry »

Older Americans may be taking hazardous drug combinations

More than 50 million older Americans – or 91 percent of that population – take at least one medication, and at least 2 million of them are combining their medication with other drugs or supplements that may be hazardous to their health, according to the Associated Press.

Read the rest of this entry »

Drug makers rush to produce new blood thinners

New blood-thinning medicines are in the works and to offer doctors more options in treatment and prevention of blood clots, according to Bloomberg. Bloomberg reports that at least six companies are working on blood thinners to take advantage of a growing need. According to Datamonitor, a London-based research company, the anticoagulation drug market is expected to reach $20 million by 2012.

Read the rest of this entry »

Low-molecular-weight heparin good therapy for cancer patients

Cancer Consultants, an oncology resource center, is reporting that prophylactic use of nadroparin, a low-molecular-weight heparin, significantly reduces the incidence of thromboembolic events in patients who have cancer and are undergoing chemotherapy. This finding was presented this week by Italian researchers with the PROTECHT Study, at the annual meeting of the American Society of Hemotology.

Read the rest of this entry »

Baxter expands heparin recall

In February, Baxter International Inc. announced it would expand its recall of heparin sodium injection products. In January, 2008, the company recalled nine lots of a heparin product as a result of reports of adverse patient reactions. It suspended production of the products in early February.

Read the rest of this entry »